Here are three observations.
1. In 2017, the market was worth $2.1 billion.
2. The spinal biologics market is anticipated to hit $2.74 billion by 2023.
3. Key market players include NuVasive, X-Spine Systems, Medtronic, Exactech, Arthrex, Zimmer Biomet, Stryker, Orthofix, Wright Medical Technology, DR PRP USA, Nutech, K2M and DePuy Synthes.
More articles on biologics:
6 things to know about Bone Biologics
Dr. Luga Podesta on stem cells in orthopedics, ‘a new frontier in medicine’
Who are the 15 major players in the global orthobiologics market?
